Pickering, Canada

Arthur Pedyczak


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arthur Pedyczak: Innovator in HIV Research

Introduction

Arthur Pedyczak is a notable inventor based in Pickering, Canada. He has made significant contributions to the field of HIV research, particularly through his innovative patents. With a total of 2 patents, Pedyczak's work focuses on the structural biology of HIV-1 and its interactions with monoclonal antibodies.

Latest Patents

Pedyczak's latest patents include the development of the Fab-epitope complex from the HIV-1 cross-neutralizing monoclonal antibody 2F5. The crystal structure of the Fab' fragment of Mab 2F5 has been elucidated, showcasing its ability to neutralize both laboratory strains and primary clinical isolates of most clades of HIV-1. This work has determined the characteristics of peptide-protein interactions, leading to the design of peptide-mimetics that are constrained in three-dimensional structure to enhance immunogenicity to the epitope sequence.

Career Highlights

Throughout his career, Pedyczak has worked with esteemed organizations such as the University of Toronto and Sanofi Pasteur Inc. His research has been pivotal in advancing the understanding of HIV-1 and developing potential therapeutic strategies.

Collaborations

Some of Pedyczak's notable coworkers include Emil F Pai and Michel Henri Klein. Their collaborative efforts have contributed to the success of his research initiatives.

Conclusion

Arthur Pedyczak's innovative work in HIV research exemplifies the impact of scientific inquiry on public health. His patents and collaborations continue to pave the way for advancements in the fight against HIV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…